X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
https://www.prnewswire.com/news-releases/roche-and-kechow-reach-a-cooperation-agreement-301358623.html
https://www.cancernetwork.com/view/fda-approves-atezolizumab-plus-cobimetinib-and-vemurafenib-for-advanced-melanoma
https://www.fiercepharma.com/pharma/embargoed-roche-s-tecentriq-added-to-cotellic-and-zelboraf-stalls-melanoma-progression
http://www.pharmatimes.com/news/hse_reimburses_braftovi_combo_1298971
https://www.biopharmadive.com/news/meet-the-protein-responsible-for-nearly-100b-in-cancer-drug-deals/561097/
https://endpts.com/roche-exelixis-cotellic-fizzles-in-pivotal-melanoma-study/
http://www.pharmafile.com/news/519891/nice-recommends-pierre-fabres-braftovi-braf-v600-mutated-advanced-melanoma
http://www.pmlive.com/pharma_news/novartis_wins_key_adjuvant_tafmek_approval_in_europe_1250603
https://www.fiercepharma.com/ready-to-challenge-novartis-and-roche-array-scores-fda-nod-for-melanoma-combo
https://www.businesswire.com/news/home/20180604005578/en/Pierre-Fabre-Partner-Array-BioPharma-Announce-Additional
https://www.biospace.com/article/array-biopharma-touts-phase-iii-results-for-melanoma-therapy/
https://endpts.com/array-mek-braf-combo-beats-out-roche-rival-in-phiii-melanoma-os-rivalry/
https://www.biospace.com/article/fda-approves-genentechs-zelboraf-thefirst-ever-drug-to-treat-specific-rare-blood-disease/
https://www.biospectrumasia.com/news/25/9756/roche-gives-free-access-to-cancer-drug-after-greek-government-altercation.html
https://www.news-medical.net/news/20171106/FDA-approves-new-drug-Zelboraf-for-Erdheim-Chester-disease.aspx
http://www.reuters.com/article/us-roche-stocks/roche-shares-hit-by-trial-flops-fears-over-biosimilar-defense-idUSKCN1BM0UG
https://endpts.com/roche-extends-losing-streak-with-a-setback-for-zelboraf-as-novartis-combo-surges-ahead/
http://www.fiercepharma.com/legal/daiichi-sankyo-s-plexxikon-goes-after-novartis-cancer-drug-patent-suit
http://www.reuters.com/article/us-novartis-chmp-recommendation-idUSKBN1631G5?rpc=401&
http://www.biospace.com/News/array-biopharma-has-a-potential-blockbuster/446411/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
http://www.fiercepharma.com/marketing/roche-s-genentech-taps-actor-morgan-freeman-for-cancer-psa
http://www.pharmatimes.com/news/roche_pushes_tecentriq_combos_into_phiii_melanoma_trials_1175878
http://www.pharmatimes.com/news/nice_nods_for_tagrisso,_cimzia_and_zepatier_1174814
http://www.pharmatimes.com/news/nice_rejects_roches_melanoma_combo_1122748
http://www.reuters.com/article/us-health-roche-britain-idUSKCN0Z21P7
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/56368a-eng.php
http://www.fiercepharmamarketing.com/story/amgen-slaps-178k-price-rare-new-leukemia-drug-blincyto/2015-11-30
http://www.pmlive.com/pharma_news/bump_in_the_road_slows_momentum_for_bms_opdivo_877188
http://www.reuters.com/article/2015/11/25/us-roche-cotellic-idUSKBN0TE1XI20151125#HEFZWU3OSsGjbZyx.97
http://www.reuters.com/article/2015/11/23/us-roche-drug-idUSKBN0TC0HH20151123#e0tcCA7YXp9IljCd.97
http://www.fiercepharmaasia.com/story/daiichi-sankyo-and-plexxikon-get-fda-nod-melanoma-combination/2015-11-11
http://www.prnewswire.com/news-releases/diplomat-to-dispense-melanoma-drug-cotellic-in-combination-with-zelboraf-300176701.html
http://www.biospace.com/News/roche-announces-strategic-plan-with-seven-trial/398010/source=TopBreaking
http://www.fiercebiotech.com/story/genentech-exelixis-score-another-phiii-success-cobimetinib/2015-10-06?utm_medium=rss&utm_source=rss&utm_campaign=rss
http://www.reuters.com/article/2015/10/06/roche-cancer-cotellic-idUSFWN12407X20151006?rpc=401
http://www.firstwordpharma.com/node/1319432?tsid=28®ion_id=5#axzz3nCSxAuGG
http://www.fiercepharma.com/story/roche-ceo-despite-china-worries-emerging-markets-will-continue-deliver-grow/2015-09-09
http://www.pmlive.com/pharma_news/roche_wins_first_approval_for_skin_cancer_drug_cotellic_810222
http://www.pharmatimes.com/Article/15-08-28/Exelixis_melanoma_combo_bags_first_global_approval.aspx
http://www.reuters.com/article/2015/04/01/roche-cancer-idUSL6N0WY1OB20150401
http://www.bloomberg.com/news/articles/2015-01-28/roche-forecasts-higher-earnings-after-2014-eps-misses-estimates
http://www.fiercepharma.com/story/get-ready-negotiate-drugmakers-payers-are-armed-drug-pricing-battle/2014-12-24
http://www.pharmamanufacturing.com/industrynews/2014/roche-exelixis-seek-fda-approval-melanoma-combo/
http://www.gene.com/media/press-releases/14580/2014-12-14/genentech-submits-new-drug-application-t
Market Place
Share 
